 |
|
Drug treatment of dyslipidemia
Sang Hyun Kim
J Korean Med Assoc. 2016;59(5):366-373. Published online 2016 May 23 DOI: https://doi.org/10.5124/jkma.2016.59.5.366
|
|
Citations to this article as recorded by
 A Prospective Single-Center Study of Incidence of Atorvastatin-Induced Myalgia in Korean Patients: Application of the Statin Myalgia Clinical Index
Kyusik Kang, Byung-Kun Kim
Journal of the Korean Neurological Association.2022; 40(1): 22. CrossRef The Effect of Lonicera Japonica Thunberg on Inflammatory Factor Expression Associated with Atherosclerosis
Ji-hae Yang, Ho-ryong Yoo, Yoon-sik Kim, In-chan Seol
The Journal of Internal Korean Medicine.2021; 42(1): 25. CrossRef Effects of Antioxidant and Anti-inflammatory Activity of Allii Macrostemonis Bulbus Cheonghyeol Plus on the Inhibition of Atherosclerosis
Incheol Chae, Juyeong Ryu, Horyong Yoo, Yoonsik Kim, Inchan Seol
Journal of Physiology & Pathology in Korean Medici.2020; 34(3): 126. CrossRef Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
Sung-Wan Kim, Hee-Ju Kang, Min Jhon, Ju-Wan Kim, Ju-Yeon Lee, Adam J. Walker, Bruno Agustini, Jae-Min Kim, Michael Berk
Frontiers in Psychiatry.2019;[Epub] CrossRef Inhibition of gene associated with Dyslipidemia and Antioxidative Effect of , and (ACR) on HepG2 cell model
Jiyun Cha, Ho-ryong Yoo, Yoon-sik Kim, In-chan Seol, Hyun-kyung Jo
Journal of Korean Medicine.2017; 38(3): 43. CrossRef Statin and the risk of new-onset diabetes mellitus
Sang-Hyun Kim
Journal of the Korean Medical Association.2017; 60(11): 901. CrossRef
|